Table 1. Relationship of high MAGE-A9 expression with clinicopathological characteristics in HCC.
MAGE-A9 | |||||
---|---|---|---|---|---|
Groups | No. | + | % | χ2 | p value |
Total | 100 | 55 | 55.0 | ||
Gender | |||||
Male | 83 | 44 | 53.0 | 0.78 | 0.377 |
Female | 17 | 11 | 64.7 | ||
Age (years) | |||||
<60 | 76 | 41 | 53.9 | 0.14 | 0.707 |
≥60 | 24 | 14 | 58.3 | ||
Tumor size (cm) | |||||
>5 | 58 | 34 | 58.6 | 0.73 | 0.392 |
≤5 | 42 | 21 | 50.0 | ||
α-fetoprotein (AFP) status | |||||
High | 56 | 28 | 50.0 | 1.29 | 0.257 |
Low | 44 | 27 | 61.4 | ||
Hepatitis B virus infection | |||||
Positive | 66 | 35 | 53.0 | 0.30 | 0.581 |
Negative | 34 | 20 | 58.8 | ||
Liver cirrhosis | |||||
Positive | 42 | 21 | 50.0 | 0.73 | 0.392 |
Negative | 58 | 34 | 58.6 | ||
Pathological grade | |||||
Grade 1 | 11 | 1 | 9.1 | 11.74 | 0.003* |
Grade 2 | 71 | 41 | 57.7 | ||
Grade 3 | 18 | 13 | 72.2 | ||
Portal vein invasion | |||||
Positive | 38 | 29 | 76.3 | 11.25 | 0.001* |
Negative | 62 | 26 | 41.9 | ||
Lymph node metastasis | |||||
Positive | 26 | 18 | 69.2 | 2.87 | 0.090 |
Negative | 74 | 37 | 50.0 | ||
Distant metastasis | |||||
Positive | 6 | 6 | 100.0 | 5.22 | 0.022* |
Negative | 94 | 49 | 52.1 | ||
TNM stage | |||||
Stage I | 13 | 4 | 30.8 | 13.05 | 0.005* |
Stage II | 36 | 15 | 41.7 | ||
Stage III | 45 | 30 | 66.7 | ||
Stage IV | 6 | 6 | 100.0 |
*p < 0.05.